Aeluma Inc is a semiconductor company specializing in sensors and communications... Show more
Aeluma, Inc. is a semiconductor company headquartered in Goleta, California, that develops photonic and electronic technologies for communications and sensing. Its proprietary platform combines compound semiconductors — III-V materials such as indium gallium arsenide and indium phosphide quantum dot lasers — with scalable, large-diameter silicon substrates to enable volume production and large-scale integration. The company's technology is aimed at applications including AI data-center optical interconnects, defense and aerospace, robotics, automotive, AR/VR, telecom and datacom, and quantum computing.
Aeluma operates a "fab-lite" model, maintaining internal epitaxy growth, prototyping, and testing capabilities while partnering with production-scale foundries and packaging companies. Investors follow the stock for its exposure to the fast-growing AI photonics theme, but it remains an early-stage, low-revenue company: fiscal 2026 revenue was about $4.46 million against a net loss of roughly $9.16 million. The company has also announced a non-binding letter of intent for up to $30 million in proposed CHIPS and Science Act funding and a collaboration with Sumitomo Chemical Advanced Technologies to accelerate photonics wafer development.
Over the last 30 days, Aeluma shares fell about 54%, declining from a closing price near $13.12 in early October to $6.00 by early November. The sell-off was punctuated by a 17% single-session drop, and the stock set a 52-week low in the process. The move was broad-based rather than a single-day event, with the stock stepping lower through mid-October as volume picked up.
The three-month picture is similarly weak. From roughly $17 in early August, the shares have fallen about 65% to current levels. The decline reflects a steady repricing from the stock's 52-week high of $31.79 down to the single digits, driven by earnings disappointment, insider sales, and waning momentum in a speculative, thinly traded name.
Several verified factors coincided with the stock's sharp decline during the 30-day window. First, the shares entered October still digesting disappointing fiscal fourth-quarter 2026 results reported in mid-September, when revenue fell 56% year over year to about $0.58 million, losses widened, and management did not provide formal fiscal 2027 guidance.
Second, insider selling added pressure. SEC filings showed CEO Jonathan Klamkin sold 100,000 shares at $10.53 — roughly $1.05 million — reported in mid-October, alongside a related Form 144 notice of proposed sale. Bearish research reports also circulated, questioning the company's revenue trajectory, its reliance on government contracts (estimated near $2.3 million), rising stock-based compensation, and a commercial III-V-on-silicon ramp not expected until 2028 or later.
These developments compounded the challenge facing a development-stage microcap with a limited float, where momentum unwinds and institutional repositioning can amplify moves. Partially offsetting the negativity, Northland initiated coverage with an Outperform rating and a $16 price target, and the company announced the appointment of Primit Parikh as a strategic advisor. Still, these did not reverse the broader downward trend during the period.
The quarterly decline is part of a larger repricing that began after the stock peaked in early August near $18. The core driver has been a fundamental reassessment: investors have moved from valuing Aeluma primarily on its AI-photonics narrative toward weighing its limited current revenue, widening losses, and a commercialization timeline that stretches toward 2028. A $30 million CHIPS Act letter of intent remains non-binding and subject to final documentation, while the company's reported government revenue base has remained modest.
Analyst actions reflect the shifting sentiment. Freedom Broker lowered its price target to $25 from $30 while maintaining a Buy rating, and the consensus average price target has drifted lower even as the formal rating remains positive. Against this backdrop, the stock has given back most of its earlier 2026 gains as speculative capital rotated out of unprofitable growth names in the semiconductor space.
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots from a much larger universe of automated strategies. Tickeron offers hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, giving traders a focused view of active market opportunities. The bots vary widely in strategy, timeframe, and performance metrics, from swing-trading approaches to longer-horizon signals, so the page can serve as a useful starting point for traders exploring systematic, data-driven methods. Those interested in automated trading can browse the curated list to see which strategies are currently resonating.
Investors are likely to focus on Aeluma's fiscal first-quarter 2027 results, which the company has scheduled to report on November 12, 2026. Key items will include revenue trends, cash burn, the status of the CHIPS Act funding, and any commentary on the Sumitomo collaboration and commercial qualification timelines. Progress on converting the non-binding CHIPS letter of intent into a definitive award, along with any signs of private commercial customers or non-recurring engineering contracts, will be closely watched. Macroeconomic conditions affecting risk appetite for speculative technology stocks, as well as any further insider activity or dilution events, are additional factors that could influence the share price. As always, these are factors to monitor rather than a basis for investment decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ALMU saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 74 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ALMU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 36 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ALMU entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +24.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMU advanced for three days, in 113 of 137 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ALMU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.365) is normal, around the industry mean (5.443). P/E Ratio (-13.442) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (45.795).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. ALMU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors